Abvc Biopharma (ABVC) Receivables - Net (2012 - 2024)
Abvc Biopharma's Receivables - Net came in at $1,529 for Q3 2024, down 0.1% from $1,530 a year earlier and down 0.1% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Receivables - Net (2012 - 2024) Analysis & Trends
At the end of FY2023, Abvc Biopharma's Receivables - Net was $839,983, up 10.9% from FY2022.
- Receivables - Net has increased in each of the last three years, with a five-year compound annual growth rate of 81.0% (FY2018 to FY2023).
- Going back by year, Receivables - Net was $757,343 in FY2022 (+169.8%), $280,692 in FY2021 (+75.7%), $159,712 in FY2020 (-2.4%) and $163,566 in FY2019 (+278.6%).
- The Q3 2024 figure represents the lowest quarterly Receivables - Net since Q2 2013.
- Year-over-year, Receivables - Net has declined for three consecutive quarters, with an average decline of 31.8% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q4 2019 (growth of 278.6%), and the weakest in Q1 2024 (a decline of 98.8%).
- Business Quant data shows ABVC's Receivables - Net at $1,530 (Q2 2024), $1,530 (Q1 2024) and $839,983 (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 1,529.00 |
| Jun 30, 2024 | 1,530.00 |
| Mar 31, 2024 | 1,530.00 |
| Dec 31, 2023 | 839,983.00 |
| Sep 30, 2023 | 1,530.00 |
| Jun 30, 2023 | 12,358.00 |
| Mar 31, 2023 | 124,133.00 |
| Dec 31, 2022 | 757,343.00 |
| Sep 30, 2022 | 47,680.00 |
| Jun 30, 2022 | 289,474.00 |
| Mar 31, 2022 | 281,197.00 |
| Dec 31, 2021 | 280,692.00 |
| Sep 30, 2021 | 331,367.00 |
| Jun 30, 2021 | 297,024.00 |
| Mar 31, 2021 | 392,532.00 |
| Dec 31, 2020 | 159,712.00 |
| Sep 30, 2020 | 146,715.00 |
| Jun 30, 2020 | 201,811.00 |
| Mar 31, 2020 | 110,217.00 |
| Dec 31, 2019 | 163,566.00 |
API Access
Abvc Biopharma Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();